Seeking Alpha
Seeking Alpha Portfolio App for iPad
Finance
(1)
Market Currents

Shares of Arena Pharmaceuticals (ARNA) jump 14% after it said late yesterday that an FDA...

  • Wednesday, May 2, 2012, 11:41 AM ET
    Shares of Arena Pharmaceuticals (ARNA) jump 14% after it said late yesterday that an FDA advisory panel will meet on Thursday next week to discuss the company's anti-obesity drug Lorcaserin. The company also said its Q1 loss per share narrowed to $0.18 from $0.35 vs. consensus of $0.13; revenue fell to $2.19M from $3.93M. (PR)
Track new comments on this story

This news story has 1 comment:

  •  
    I would love Lorcaserin to be approved, and this stock to do well long term. I don't know why, but this stock seems to be a magnet for negative criticism.
    2 May 2012, 11:49 AM Reply Like
LATEST|
TODAY SO FAR|
YESTERDAY
Other date
DJIA (DIA) S&P 500 (SPY)
Latest Articles
More Latest Articles »